Z-1297-2023Class II
PCRopsis Activator: a) 1.5mL, REF 228001; b) 0.5mL,REF 228002; nucleic acid extraction from a variety of...
Entopsis, Inc. / initiated 2023-02-21 / Open, Classified / root cause: labeling and UDI
Entopsis , Inc. began a recall of PCRopsis Activator: a) 1.5mL, REF 228001; b) 0.5mL,REF 228002; nucleic acid extraction from a variety of biological samples on . FDA classified it as Class II and gives the reason as "Presence of misleading label statements on the product label". As of , the recall status on record is Open, Classified, and MDM tags the root cause as labeling and UDI.
Recall record
- Recall number
- Z-1297-2023
- Classification
- Class II
- Status
- Open, Classified
- Initiated
- Posted
- Recalling firm
- Entopsis, Inc.
- Product
- PCRopsis Activator: a) 1.5mL, REF 228001; b) 0.5mL,REF 228002; nucleic acid extraction from a variety of biological samples
- Product code
- JJH Clinical Sample Concentrator
- Reason for recall
- Presence of misleading label statements on the product label.
- Root cause tag
- labeling and UDI
- FDA root cause
- Under Investigation by firm
- Action
- The firm issued a MEDICAL DEVICE RECALL notice to its consignees on 02/21/22023 by email. Those without a valid email address were mailed the notice via certified mail. The notice explained the issue and risk and requested the customer/user take the following actions: "Entopsis Inc., requests that the product lots listed below - shipped/received before February 8st, 2023 be promptly discontinued from use and discarded from inventory as per your non-hazardous waste disposal plan.The labeling of PCRopsis products was revised on February 8th, 2022. Updated statements of intended use and revised instructions for use are available on www.pcropsis.com. If you are currently using or intend to use the PCRopsis product lots affected by this recall please contact us at [email protected] or 1-888-407-5070 (Monday to Friday 9.00 AM to 4.30 PM Eastern Time) to request a replacement. If you are a re-distributor of PCRopsis devices, notify your end customer with a copy of this letter. Please acknowledge the removal of affected product lots by filling out the attached acknowledgment form and returning it to us at [email protected]. Contact us at [email protected] or 1-888-407-5070 - Monday to Friday 9.00 AM to 4.30 PM US Eastern Time (GMT -5) with any questions you may have."
- Quantity in commerce
- 52 units
- Distribution
- Nationwide and Canada, UK, Portugal, England, Spain, England , Germany, Brazil, Denmark, KOR, South Korea, Colombia, Lithuania
- Product codes and lots
- a) REF 282001: Lot Numbers: 3, Exp. 05/2023; 4, Exp. 07/2023; b) REF 228002: Lot Numbers: 3, Exp. 05/2023; 4, Exp. 07/2023; 5, Exp. 04/2023
Enforcement reports
One row per recalled product line| Recall number | Class | Status | Voluntary or mandated | Report date | Classified |
|---|---|---|---|---|---|
| Z-1295-2023 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-1296-2023 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-1297-2023 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-1298-2023 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-1299-2023 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-1300-2023 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-1301-2023 | Class II | Ongoing | Voluntary: Firm initiated |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
